UNSPSC 51271602: Bumecaine

This classification denotes an anesthetic agent with the molecular formula C18H28N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B77K612SPZ, chemically known as 2-pyrrolidinecarboxanilide, 1-butyl-2,4,6-trimethyl- but generally known as bumecaine, which bears US NIH Compound Identifier 65770. Bumecaine most often comes in base and hydrochloride forms. European Medicines Agency schedules Bumecaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05969MIG.

UNSPSC 51271602 Bumecaine is a Commodity code covering a local anesthetic pharmaceutical product. State and local governments procure bumecaine primarily for use in healthcare delivery settings — hospitals, clinics, emergency departments, and other medical facilities operated or contracted by public health agencies. The drug is typically purchased as part of broader pharmaceutical supply contracts or as a standalone line item within anesthesia and pain-management procurement. Public health departments, correctional health services, and municipal and county healthcare systems are the primary issuing bodies under this code.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted solicitations, RFPs, RFQs, or awarded contracts to reference, no geographic concentration, issuing-body activity, or representative procurement examples can be identified.